 Repare Therapeutics Inc NASDAQ: RPTX, a top clinical-stage precision oncology corporation, announced that its executed a collaboration and worldwide license deal with Roche for both the commercialization and development of RP-3500 also known as camonsertib. This new shot up the companys stock price by 25. 